Boryung Corporation (KRX:003850)

South Korea · Delayed Price · Currency is KRW

10,070

-120 (-1.18%)

Last updated: Feb 26, 2026, 11:44 AM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '12 Dec 31, 2012
Pharmaceutical Manufacturing and Sales	1.02T	859.63B	760.48B	627.28B	561.87B
Pharmaceutical Manufacturing and Sales Growth	18.32%	13.04%	21.23%	11.64%	7.17%
Total	1.02T	859.63B	760.48B	627.28B	561.87B
Total Growth	18.32%	13.04%	21.23%	11.64%	7.17%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '12 Dec 31, 2012
The Republic of Korea	1.05T	892.26B	796.35B	657.47B	576.94B
The Republic of Korea Growth	17.19%	12.04%	21.12%	13.96%	10.05%
Asia	624.59M	608.24M	487.02M	-	-
Asia Growth	2.69%	24.89%	-	-	-
The Adjustments and Removal	-30.21B	-34.53B	-	-	-
North America	1.09B	1.29B	1.81B	1.03B	235.41M
North America Growth	-15.40%	-28.93%	75.30%	339.41%	-
Internal Sales	-	-	-38.18B	-31.23B	-15.31B
Total	1.02T	859.63B	760.48B	627.28B	561.87B
Total Growth	18.32%	13.04%	21.23%	11.64%	7.17%

Source: S&P Global Market Intelligence.